SMX Revenue and Competitors
Estimated Revenue & Valuation
- SMX's estimated annual revenue is currently $56.2M per year.
- SMX's estimated revenue per employee is $181,250
Employee Data
- SMX has 310 Employees.
SMX's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Finance and Commercial | Reveal Email/Phone |
2 | New Zealand - Channel Sales Manager | Reveal Email/Phone |
3 | Senior Operations Engineer | Reveal Email/Phone |
SMX Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.4M | 24 | N/A | N/A | N/A |
#2 | $0.2M | 3 | N/A | N/A | N/A |
#3 | $2.4M | 24 | N/A | N/A | N/A |
#4 | $2.2M | 22 | N/A | N/A | N/A |
#5 | $0.3M | 4 | N/A | N/A | N/A |
#6 | $1.6M | 13 | N/A | N/A | N/A |
#7 | $0.7M | 9 | N/A | N/A | N/A |
#8 | $0.4M | 6 | N/A | N/A | N/A |
#9 | $0.2M | 3 | N/A | N/A | N/A |
#10 | $39.7M | 249 | 19% | N/A | N/A |
#11 | $24.1M | 118 | 2% | $12.3M | N/A |
#12 | $16.2M | 112 | N/A | N/A | N/A |
#13 | $4.1M | 35 | N/A | N/A | N/A |
#14 | $8M | 49 | N/A | N/A | N/A |
What Is SMX?
N/A
Total Funding
310
Number of Employees
$56.2M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
SMX News
2022-04-20 - Moraxella Catarrhalis: Infections, Transmission, Antibiotics
They include amoxicillin-clavulanate, doxycycline, clarithromycin, and trimethoprim-sulfamethoxazole (TMP/SMX), which show strong...
2022-03-30 - SMX Welcomes Daniel Dant as Vice President of Strategy and ...
HERNDON, Va., April 05, 2022 (GLOBE NEWSWIRE) -- SMX today announced the appointment of Daniel Sphinx Dant as the vice president of...
2022-03-30 - SMX successfully enables industrial 'three times loop' recycled ...
MELBOURNE, Australia, April 5, 2022 /PRNewswire/ -- Security Matters Limited (ASX: SMX), a company focusing on digitising physical objects...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $58.1M | 310 | -10% | N/A |
#2 | $94.9M | 310 | 8% | N/A |
#3 | $81.4M | 310 | N/A | N/A |
#4 | $69.8M | 310 | 5% | N/A |
#5 | $15M | 310 | -1% | N/A |